Many studies indicate that ubiquitination contributes to both AR degradation and AR transcriptional activity which is dependent on ubiquitinated residues [20,[33], [34], [35], [36]], and some ubiquitin E3 ligases targeting AR have been identified in prostate cancer. This evidence concerns the gene AR and prostate carcinoma.